Medication non-adherence and asthma treatment cost Bruce G. Bender a and Cynthia Rand b
|
|
- Miranda Craig
- 8 years ago
- Views:
Transcription
1 Medication non-adherence and asthma treatment cost Bruce G. Bender a and Cynthia Rand b Purpose of review The purpose of this review is to describe the impact of asthma treatment non-adherence on patients and the healthcare system, and to outline areas of responsibility towards improved adherence. Recent findings The average cost of healthcare expenses for each person in the United States in 2002 was US$5440. In that year, there were 800 million medical encounters. However, adherence research suggests that a significant portion of the healthcare advice and prescriptions dispensed in these encounters was wasted. The annual cost to the healthcare system caused by non-adherence has been estimated at US$300 billion dollars. The responsibility for improving adherence has usually been placed on the patient and healthcare provider. However, if non-adherence is to be more effectively addressed, other components of the healthcare and pharmaceutical industries must also take responsibility. Summary Treatment non-adherence compromises treatment effectiveness and drives up the healthcare costs related to asthma and other chronic conditions. Collaborative efforts to improve adherence to treatments for chronic illness, recently promoted by the World Health Organization, must include multiple components of the healthcare system, must recognize that the costs of adherence promotion are outweighed by cost savings after improved adherence, and must support research to develop new and better strategies for improving adherence. Keywords adherence, asthma, cost Curr Opin Allergy Clin Immunol 4: # 2004 Lippincott Williams & Wilkins. a Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado, USA; and b Division of Pulmonary and Critical Care Medicine, Johns Hopkins University Medical Center, Baltimore, Maryland, USA Correspondence to Bruce G. Bender, PhD, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA Fax: ; benderb@njc.org Current Opinion in Allergy and Clinical Immunology 2004, 4: Abbreviation WHO World Health Organization # 2004 Lippincott Williams & Wilkins Introduction Patient non-adherence to treatments for chronic illness compromises treatment success and patient quality of life while increasing healthcare costs. A recent World Health Organization (WHO) book addressed the worldwide problem of treatment non-adherence, which averages only 50% in developed countries and is even lower in developing countries, and concluded that increasing adherence may have a more beneficial impact on the health of the population than improving specific treatments [1.. ]. The WHO report is targeted at policy-makers and health managers in order to increase awareness of the far-reaching problem of poor adherence rates among patients with chronic illness and to stimulate multidisciplinary efforts to increase adherence. Healthcare costs related to non-adherence The United States is the largest consumer of healthcare in the world, with total health costs reaching US$1.6 trillion in 2002, representing 14.9% of the gross domestic product [2]. The average cost of healthcare expenses for each person in the USA in 2002 was US$5440, with an average of 3.1 physician office visits per person [2], resulting in a total of over 880 million physician office visits. However, adherence research suggests that a significant portion of the healthcare advice and prescriptions dispensed at these 880 million medical encounters was wasted. DeMatteo [3] estimated that over 188 million medical visits result in patients failing to adhere to physician advice. Although acknowledging that it is impossible to estimate precisely the waste and excess cost associated with non-adherence, the meta-analysis by DeMatteo [3] on the prevalence of non-adherence suggests that the costs may be as high as US$300 billion a year. Even more troubling are the healthcare costs resulting from non-adherence-related disease exacerbations. For example, when a non-adherent asthma patient presents with continuing symptoms, the physician may unnecessarily step up therapy because he or she believes that the patient is non-responsive to the original less intensive, and less costly, therapy. In addition, when a patient fails to respond to an apparently appropriate therapy, the physician may feel compelled to order expensive diagnostic tests to try and understand the patient s poor response to treatment. Although not all non-adherence results in dangerous or costly complications, research across a range of chronic diseases, including asthma, suggests that non-adherence results DOI: /01.all cf 191
2 192 Outcome measures in excess urgent care and hospitalizations. For example, Milgrom et al. [4] demonstrated that pediatric asthma patients who were the least adherent were more likely to have asthma exacerbations requiring a prednisone burst. On a national level, Iskedjian et al. [5] estimated the economic burden of hospitalization attributable to patient non-adherence with controller therapy in Canada. Using national health statistics and an average admission rate as a result of non-adherence of 5.2% (based on literature review), they concluded that Canadian hospital expenditures caused by nonadherence exceeded US$1.6 billion. Finally, even when patients follow physician advice as far as filling prescriptions and initiating therapy, research suggests that a portion of all prescribed medication is wasted or discarded. For example, a study by Morgan [6] used home-based pill counts and surveys to examine the economic impact of wasted prescriptions among older outpatients (465 years). Morgan [6] found that waste (i.e. no intention of using remaining medication) represented 2.3% of total medication costs and that the average annual cost of the wasted medication was US$30.47 (range US$ ). The study estimated that this modest perperson cost of waste would translate into a national cost for adults older than 65 years of age of over US$1 billion per year. The overall implications of these analyses are clear and compelling. As healthcare costs spiral upwards and national health policy debates consider severe limitations on healthcare benefits, strategies to reduce non-adherence-related costs offer a promising (and cost-effective) avenue for intervention and cost-savings. Changing patient behavior Despite a large published literature addressing the problem of how to change patient behavior in order to improve medication adherence, remarkably little success has been recorded. Patients in adherence intervention studies may achieve higher scores on a test of asthma knowledge, and report increased medication use, but most frequently an objectively established change in disease status is not achieved [1..,7]. Because many factors can contribute to treatment non-adherence, no single intervention will affect change in each individual. Patient understanding of the disease and its treatment is essential for treatment adherence and improved outcomes, but studies employing comprehensive asthma education programmes often do not result in significant change [1..,7]. Patient education remains an important component in the comprehensive care of asthma, but it is likely to affect change only in that group of patients for whom a lack of information is the primary reason for non-adherence. Changing adherence behavior is a difficult but not impossible task. Smoking, which is both physiologically and psychologically addicting, is a behavior very resistant to change. Nonetheless, comprehensive efforts to reduce smoking frequency have resulted in a decrease over the past 25 years in the proportion of Americans who smoke. Furthermore, the Surgeon General s Report in 2000 outlined a plan for cutting US smoking rates in half that included: (1) the implementation of school-based antitobacco programmes; (2) a media campaign including anti-tobacco messages from popular celebrities; (3) encouragement of the inclusion of state-of-the-art smoking cessation programmes in health insurance plans; (4) the training of physicians to address tobacco cessation more effectively; (5) the passage of legislation that would include stricter indoor air regulations; and (6) increased funding to develop more effective smoking cessation interventions. The application of a broad spectrum of strategies that influence behavior may similarly help to improve the self-management of chronic medical conditions including asthma, diabetes, and hypertension. Whereas the healthcare provider has the most direct contact with patients and therefore the greatest opportunity to affect behavior change, the caregiver cannot alone improve the patient s management of chronic illness, relieve the patient of disease burden, and reduce healthcare costs. In a recent report, WHO sited the worldwide problem of the treatment of non-adherence in both developed and developing countries and across all chronic conditions, including communicable diseases such as tuberculosis and HIV/AIDS, mental and neurological conditions such as depression and epilepsy, substance dependence, and a range of other conditions including asthma, hypertension, and cancer. The international panel of writers of the WHO report took the following position with regard to which elements of the healthcare system must assume responsibility for improving disease management: Over the past few decades we have witnessed several phases in the development of approaches aimed at ensuring that patients continue therapy for chronic conditions for long periods of time. Initially the patient was thought to be the source of the problem of compliance. Later, the role of the providers was also addressed. Now we acknowledge that a systems approach is required. The idea of compliance is associated too closely with blame, be it of providers or patients, and the concept of adherence is a better way of capturing the dynamic and complex changes required of many players over long periods to maintain optimal health in people with chronic diseases [1.. ]. Widespread change in the patient self-management of chronic illness will occur when, as with the campaign to
3 Medication non-adherence and asthma treatment cost Bender and Rand 193 lower smoking rates, the problem is approached from multiple avenues using multiple strategies. To accomplish this, neither the patient nor the healthcare provider can be expected to assume sole responsibility for effective disease self-management. The healthcare provider, healthcare industry, and pharmaceutical industry must all accept responsibility for helping enable patients to care for their asthma better. Healthcare provider The relationship between the healthcare giver and the patient has a large influence on whether the patient will engage in healthcare behaviors sufficient to ensure successful treatment of the disease. The Expert Panel Report: Guidelines for the diagnosis and management of asthma [8] emphasized that patient education must occur within this caregiver patient partnership. This relationship has a more powerful influence on adherence than almost any other factor [9,10]. The strength of the physician patient treatment alliance, as rated by the physician, predicted treatment adherence and non-routine office visits in the year after hospitalization of 60 adolescents with severe, chronic asthma [11]. In psychotherapy for emotional disorders, stronger therapeutic alliance has similarly been positively related with better outcomes [12]. In some cases, the behavior and attitude of the patient prevents the healthcare giver from developing an optimal working relationship. However, there is considerable evidence that the behavior of the physician plays a significant role in defining the strength of the treatment alliance. Patients are more adherent to their treatment regimen when their physician has answered all the patient s questions [13] and communicated clearly [14] and positively [15. ]. The physician s interest in spending time with a patient, attempting to understand his/her beliefs and perceptions about the illness, communicates the desire to develope a partnership that will result in treatment success [15. ]. Healthcare industry The healthcare industry includes insurance companies, health maintenance organizations, and the hospitals, clinics, and medical centers that provide clinical care. The needs and objectives of these organizations are sometimes in conflict. For example, the amount and type of healthcare that medical facilities may wish to offer is restricted by patients healthcare insurance policies. Furthermore, the need for insurance providers and health maintenance organizations to remain profitable may at times conflict with the patient s wish to receive quality healthcare in a rapid and unrestricted manner. Nonetheless, the objectives of increased patient adherence and consequent improved disease control are in the best interests of both the healthcare industry and the patient. Patients who are adherent to their treatment plan and are able to self-manage a chronic illness effectively are less burdensome to healthcare providers. Such patients are less frustrating to their provider and are less likely to require emergency medical services, in turn saving money for the insurer. Because many emergency room visits and hospitalizations for asthma can be traced to treatment nonadherence [16], increased adherence can be cost saving for insurance and health maintenance organizations. Inadequate disease management frequently underlies the largest healthcare costs related to asthma, including on average more than US$500 per emergency room visit and US$2000 per hospitalization [17]. Urgent care, including hospital stays and visits to the emergency room or urgent care clinic, amount to almost US$2 billion [18]. When indirect costs such as work absenteeism are taken into account, the total cost of poorly controlled asthma is much higher [19]. The potential cost-savings achieved by promoting adherence must be weighed against the apparent cost savings of restricting access to care, shortening office visits, and passing increasing medication costs to patients. Physicians and other care providers who experience pressure to see more patients in shorter office visits often report that they are allowed insufficient time to address patient adherence [20]. If increased emergency room and hospital visits by patients who are not well motivated or informed about caring for their illness are at least partly the result of shortened office visits, then the apparent cost savings resulting from seeing more patients in less time are not real. Similarly, the apparent cost savings anticipated when insurance companies shift increasing medication cost to patients must be calculated against the cost resulting when patients stop taking medication for their heart disease [21]. Pharmaceutical industry Drug development, manufacturing, marketing, and pricing all have a potential impact on patient acceptance and adherence. That patients are more adherent to medications that are easily taken has been understood for many years [22 25]. Recognizing these phenomena, pharmaceutical firms have increasingly attempted to develop once-daily treatments, to obtain US Food and Drug Administration approval to convert multiple-dosing regimens to once a day, and to produce asthma medications with tablets rather than inhaler delivery systems. Developing medications with higher patient acceptance helps adherence, but the pharmaceutical industry could do more to assist in the pursuit of improved selfmanagement. Much of the research in the adherence to
4 194 Outcome measures asthma metered-dose inhalers has advanced because of the availability of electronic devices that allow researchers to collect information about the patterns of medication use. The most recent generation of dry-powder inhaled medications include a variety of delivery systems that do not accept electronic adherence-tracking equipment. As new asthma medications are developed, the inclusion of technology that can be adapted to monitor adherence would represent an important contribution to increasing patient adherence. Improvement in medication labels and package inserts may also promote better adherence. Most labeling regulations are content based, and few package inserts are written to be easily read by patients or to be informative and adherence promoting. Most patients throw away the inserts without reading them. An exception to this is found in Australia, where performance-based and tested package inserts are consumer friendly, written clearly and in a manner that makes them useful and encouraging to patients [1.. ]. Finally, it would be helpful for pharmaceutical firms to consider the growing phenomenon of patient rejection of new, expensive drugs for which they are expected to shoulder a large portion of cost in their insurance plan. The management of high medication costs must be the responsibility of the pharmaceutical industry as well as the health insurance industry, the care provider, and the patient. Conclusion Treatment non-adherence compromises treatment effectiveness and drives up healthcare costs related to asthma and other chronic conditions. The responsibility for improving adherence has usually been placed on the patient and healthcare provider. However, if nonadherence is to be more effectively addressed, other components of the healthcare industry must also take responsibility. Healthcare systems, including many health maintenance organizations, often direct the length and duration of treatment, including the amount of time healthcare givers are able to spend with patients. They determine reimbursements and fee structures, the allocation of resources for physician training, procedures for the continuity of care, and the manner in which information about patient progress is recorded and tracked. A consideration of their impact on adherence when health delivery systems are designed can contribute significantly to the improved self-management of asthma and other chronic illnesses. Finally, collaborative efforts to improve adherence to treatments for chronic illness, recently promoted by WHO [1.. ] may follow the success of anti-tobacco efforts, including an adherence-promoting message conveyed in the popular media, communication training for physicians, and increased funding to test new adherence intervention strategies. References and recommended reading Papers of particular interest, published within the annual period of review, have been highlighted as:. of special interest.. of outstanding interest 1.. Sabate E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; An international group of authors make the case for the large degree to which the treatment non-adherence in both developing and developed countries leads to poorly controlled illness. 2 National Ambulatory Medical Care Survey Available at: [Accessed 15 January 2004] 3 DeMatteo D. Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; (in press). 4 Milgrom H, Bender B, Ackerson L, et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: Iskedjian M, Addis A, Einarson TR. Estimating the economic burden of hospitalization due to patient nonadherence in Canada. Value Health 2002; 5: Morgan TM. The economic impact of wasted prescription medication in an outpatient population of older adults. J Family Pract 2001; 50: Bernard-Bonnin A-C, Stachenko S, Bonin D, et al. Self-management teaching programs and morbidity of pediatric asthma: a meta-analysis. J Allergy Clin Immunol 1995; 95: National Heart Lung and Blood Institute. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. Washington, DC: US Department of Health and Human Services; Cromer BA. Behavioral strategies to increase compliance in adolescents. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press; pp Stewart MA. Effective physician patient communication and health outcomes: a review. Can Med Assoc J 1995; 152: Gavin LA, Wamboldt MZ, Sorokin N, et al. Treatment alliance and its association with family functioning, adherence, and medical outcome in adolescents with severe, chronic asthma. J Pediatr Psychol 1999; 24: Krupnick JL, Sotsky SM, Simmens S, et al. The role of the therapeutic alliance in psychotherapy and pharmocotherapy outcome: findings in the National Institute of Mental Health treatment of depression collaborative research program. J Consult Clin Psychol 1996; 64: DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians characteristics influence patients adherence to medical treatment: results from the medical outcomes study. Health Psychol 1993; 12: Armstrong D, Glanville T, Bailey E, O Keefe G. Doctor-initiated consultations: a study of communication between general practitioners and patients about the need for reattendance. Br J Gen Pract 1990; 40: Apter AJ, Boston RC, George M, et al. Modifiable barriers to adherence to inhaled steroids among adults with asthma: it s not just black and white. J Allergy Clin Immunol 2003; 111: Factors influencing adherence that can be modified include knowledge about the medication, patient-perceived adequacy of communication with the provider, social support, attitude, depression, and self-efficacy. 16 Bauman LJ, Wright E, Leickly FE, et al. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics 2002; 110: Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001; 107: Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003; 111: Birnbaum HG, Berger WE, Greenberg PE, et al. Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol 2002; 109:
5 Medication non-adherence and asthma treatment cost Bender and Rand Ammerman AS, DeVellis RF, Carey TS, et al. Physician-based diet counseling for cholesterol reduction: current practices, determinants, and strategies for improvement. Prevent Med 1993; 22: Huskamp HA, Deverka PA, Epstein AM, et al. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med 2003; 349: Becker MH, Matman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975; 13: Cramer J, Mattson R, Prevey M, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 54: Jones C, Santanello NC, Boccuzzi SJ, et al. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 2003; 40:
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Medication Adherence Services
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Introduction Medication adherence can be generally defined as the extent to which a patient takes medication as prescribed by his
More information10/31/2014. Medication Adherence: Development of an EMR tool to monitor oral medication compliance. Conflict of Interest Disclosures.
Medication Adherence: Development of an EMR tool to monitor oral medication compliance Donna Williams, RN PHN Carol Bell, NP MSN Andrea Linder, RN MS CCRC Clinical Research Nurses Stanford University SOM
More informationBACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes
BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective
More informationPRESCRIPTION MEDICINES: COSTS IN CONTEXT
PRESCRIPTION MEDICINES: COSTS IN CONTEXT 2015 Since 2000, biopharmaceutical companies have brought MORE THAN 500 NEW TREATMENTS AND CURES to U.S. patients In the last 100 years, medicines have helped raise
More informationAn Introduction to Medication Adherence
An Introduction to Medication Adherence Medication Adherence Project (MAP) A project of the Cardiovascular Prevention & Control Program and the Fund for Public Health in New York Drugs don t work in patients
More informationApril 28, 2014. Submitted electronically via www.regulations.gov
April 28, 2014 Department of Health and Human Services Office of the National Coordinator for Health Information Technology Attention: 2015 Edition EHR Standards and Certification Criteria Proposed Rule
More informationMental Health Referral Practices and Diabetic Management at Community Medical Alliance Clinic (Bell Site) Northeast Community Clinic (NECC)
Mental Health Referral Practices and Diabetic Management at Community Medical Alliance Clinic (Bell Site) Northeast Community Clinic (NECC) MaryAnn Garcia, SUNY Downstate Medical College NMF PCLP Scholar
More informationAchieving Quality and Value in Chronic Care Management
The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of
More informationConcept Series Paper on Disease Management
Concept Series Paper on Disease Management Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing
More informationCommunity Care of North Carolina
Community Care of North Carolina CCNC Transitional Care Management Jennifer Cockerham, RN, BSN, CDE Director, Chronic Care Programs & Quality Management 1 Chronic Care Population Within the NC Medicaid
More informationChronic Disease and Nursing:
Chronic Disease and Nursing: A Summary of the Issues What s the issue? Chronic diseases are now the major global disease problem facing the world and a key barrier to development, to alleviating poverty,
More informationRe: CMS-1345-P; Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations; Proposed Rule
Department of Health and Human Services Attention: CMS 1345 P P.O. Box 8013, Baltimore, MD 21244 8013 Re: CMS-1345-P; Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations;
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationWHEREAS updates are required to the Compensation Plan for Pharmacy Services;
M.O. 23/2014 WHEREAS the Minister of Health is authorized pursuant to section 16 of the Regional Health Authorities Act to provide or arrange for the provision of health services in any area of Alberta
More informationOverview Medication Adherence Where Are We Today?
Overview Medication Adherence Where Are We Today? This section covers the following topics: Adherence concepts and terminology Statistics related to adherence Consequences of medication nonadherence Factors
More informationWasteful spending in the U.S. health care. Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs
Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs by Christopher J. Mathews Wasteful spending in the U.S. health care system costs an estimated $750 billion to $1.2 trillion
More informationClinical Nurse Specialists Practitioners Contributing to Primary Care: A Briefing Paper
Clinical Nurse Specialists Practitioners Contributing to Primary Care: A Briefing Paper As the need grows for more practitioners of primary care, it is important to recognize the Clinical Nurse Specialist
More informationBipolar Disorder and Substance Abuse Joseph Goldberg, MD
Diabetes and Depression in Older Adults: A Telehealth Intervention Julie E. Malphurs, PhD Asst. Professor of Psychiatry and Behavioral Science Miller School of Medicine, University of Miami Research Coordinator,
More informationDr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing
Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing Overview Depression is significantly higher among elderly adults receiving home healthcare, particularly among
More informationTelehealth Solutions Enhance Health Outcomes and Reduce Healthcare Costs
Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Telehealth Solutions Enhance Health Outcomes and
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Core Benefit for Primary Care and Specialty Treatment and Prevention of Alcohol, Nicotine and Other Drug PREFACE Statement of the Problem:
More informationBreathe With Ease. Asthma Disease Management Program
Breathe With Ease Asthma Disease Management Program MOLINA Breathe With Ease Pediatric and Adult Asthma Disease Management Program Background According to the National Asthma Education and Prevention Program
More informationMedStar Family Choice (MFC) Case Management Program. Cyd Campbell, MD, FAAP Medical Director, MFC MCAC June 24, 2015
MedStar Family Choice (MFC) Case Management Program Cyd Campbell, MD, FAAP Medical Director, MFC MCAC June 24, 2015 Case Management Program Presentation Overview CM Programs Disease Management Complex
More informationBritish Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes
British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes Introduction Self-monitoring of blood glucose (SMBG) is in widespread use among
More informationHealth Coaching for Chronic Conditions Engaging and Supporting Patients to Self Manage
Engaging and Supporting Patients to Self Manage Scope of Chronic Disease Institute for Optimizing Health Outcomes Durhane Wong-Rieger, PhD Chronic diseases are the leading cause of death and disability
More information8/14/2012 California Dual Demonstration DRAFT Quality Metrics
Stakeholder feedback is requested on the following: 1) metrics 69 through 94; and 2) withhold measures for years 1, 2, and 3. Steward/ 1 Antidepressant medication management Percentage of members 18 years
More informationElderly males, especially white males, are the people at highest risk for suicide in America.
Statement of Ira R. Katz, MD, PhD Professor of Psychiatry Director, Section of Geriatric Psychiatry University of Pennsylvania Director, Mental Illness Research Education and Clinical Center Philadelphia
More informationApproaches to Asthma Management:
Approaches to Asthma Management: BY CAROL MCPHILLIPS-TANGUM AND CAROLINE M. ERCEG ASTHMA IS A CHRONIC DISEASE that affects millions of people in the United States and disproportionately impacts children,
More informationMedical Management. G.2 At a Glance. G.3 Procedures Requiring Prior Authorization. G.5 How to Contact or Notify Medical Management
Page1 G.2 At a Glance G.3 Procedures Requiring Prior Authorization G.5 How to Contact or Notify G.6 When to Notify G.11 Case Management Services G.14 Special Needs Services G.16 Health Management Programs
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationIntegration of Pharmacists Clinical Services in the Patient-Centered Primary Care Medical Home. March 2009
Integration of Pharmacists Clinical Services in the Patient-Centered Primary Care Medical Home March 2009 Introduction: The potential promise and value of the patient-centered primary care medical home
More informationOutcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
More informationIntegrating Mental Health and Substance Abuse Care With HIV/AIDS Prevention. John Anderson, PhD Bob Bongiovanni, MA Leigh Fischer, MPH Jeff Basinger
Integrating Mental Health and Substance Abuse Care With HIV/AIDS Prevention John Anderson, PhD Bob Bongiovanni, MA Leigh Fischer, MPH Jeff Basinger Who Am I and Where do I work? John Anderson, PhD Senior
More informationShaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact
Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact Task Force for the National Conference on Diabetes: The Task Force is comprised of Taking Control of
More informationCQMs. Clinical Quality Measures 101
CQMs Clinical Quality Measures 101 BASICS AND GOALS In the past 10 years, clinical quality measures (CQMs) have become an integral component in the Centers for Medicare & Medicaid Services (CMS) drive
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
More informationPredicting Medication Compliance and Persistency
Predicting Medication Compliance and Persistency By: Jay Bigelow, President Amanda Rhodes, M.P.H., C.H.E.S., Vice President Behavioral Solutions MicroMass Communications, Inc. Introduction A widely recognized
More informationWelcome to Magellan Complete Care
Magellan Complete Care of Florida Provider Newsletter Welcome to Magellan Complete Care On behalf of Magellan Complete Care of Florida, thank you for your continued support and collaboration. As the only
More informationOur Mission. How does Colorado Medicaid Work? Objectives
How does Colorado Medicaid Work? Understanding the Delivery of Pharmaceutical Care Cathy Traugott, JD, RPh Client and Clinical Care Office Pharmacy Unit Manager Department of Health Care Policy and Financing
More informationPopulation Health Management Program
Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care
More informationKENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
More informationDisease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification
Disease Management UnitedHealthcare Disease Management (DM) programs are part of our innovative Care Management Program. Our Disease Management (DM) program is guided by the principles of the UnitedHealthcare
More informationWashington Common Measure Set on Healthcare Quality. Behavioral Health Measure Selection Workgroup Meeting #2 September 14, 2015
Washington Common Measure Set on Healthcare Quality Behavioral Health Measure Selection Workgroup Meeting #2 September 14, 2015 Today s Meeting Agenda 1. Welcome, Member Introductions 2. Review: Public
More informationIntegrated Health Systems: Promise And Performance
Integrated Health Systems: Promise And Performance Stephen M. Shortell, Ph.D. Blue Cross of California Distinguished Professor of Health Policy and Management Professor of Organization Behavior Dean, School
More informationBoth mental illness and addiction are real medical conditions, just like diabetes, cardiovascular disease and heart disease. In terms of addiction,
The State of Behavioral Health The State of Behavioral Health in Oklahoma Mental Illness and Addiction: Diseases of the Brain Both mental illness and addiction are real medical conditions, just like diabetes,
More informationBehavioral Health Forum 2014 Description of 4 Mental Health Service areas
Behavioral Health Forum 2014 Description of 4 Mental Health Service areas Terri Timberlake, Ph.D. Director, Adult Mental Health Department of Behavioral Health and Developmental Disabilities Core Eligibility
More informationGUIDE TO PATIENT COUNSELLING
Guide To Patient Counselling page - 1 - GUIDE TO PATIENT COUNSELLING Communication is the transfer of information meaningful to those involved. It is the process in which messages are generated and sent
More informationA pharmacist s guide to Pharmacy Services compensation
Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2015/12) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription
More informationLEARNING WHAT WORKS AND INCREASING KNOWLEDGE
About This Series In February 2010, the George Washington University School of Public Health and Health Services, Department of Health Policy released Changing po 2 licy: The Elements for Improving Childhood
More information4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents)
4.40 STRUCTURED DAY TREATMENT SERVICES 4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents) Description of Services: Substance use partial hospitalization is a nonresidential treatment
More informationNational Learning Objectives for COPD Educators
National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the
More informationDelivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD)
Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD) Learning Objectives Upon completion of this module, you should be able to: Describe how
More informationBreathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease
Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease By John W. Walsh, Co-Founder and President of the COPD Foundation Breathing Easier In
More informationAn Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
More informationCompensation Plan for Pharmacy Services
Compensation Plan for Pharmacy Services Attachment A Section 1 - Definitions ABC Pharmacy Agreement means an agreement between ABC and a Community Pharmacy as described in Schedule 2.1 of the Alberta Blue
More information3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients
Faculty Disclosures COPD Disease Management Tackling the Transition Dr. Cappelluti has no actual or potential conflicts of interest associated with this presentation. Jane Reardon has no actual or potential
More informationTRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
More informationModify the Institutions for Mental Disease (IMDs) exclusion for capitation payments
July 27, 2015 Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-2390-P 7500 Security Boulevard Baltimore, MD 21244 SUBMITTED ELECTRONICALLY Re: CMS-2390-P:
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder,
More informationBenefits of a Working Relationship Between Medical and Allied Health Practitioners and Personal Fitness Trainers
Benefits of a Working Relationship Between Medical and Allied Health Practitioners and Personal Fitness Trainers Introduction The health benefits of physical activity have been documented in numerous scientific
More informationWHO Consultation on the Zero Draft Global Mental Health Action Plan 2013-2020 International Diabetes Federation (IDF) Submission
WHO Consultation on the Zero Draft Global Mental Health Action Plan 2013-2020 International Diabetes Federation (IDF) Submission The International Diabetes Federation (IDF), an umbrella organisation of
More informationMedical Management. G.2 At a Glance. G.3 Procedures Requiring Prior Authorization. G.5 How to Contact or Notify Medical Management
G.2 At a Glance G.3 Procedures Requiring Prior Authorization G.5 How to Contact or Notify Medical Management G.6 When to Notify Medical Management G.9 Case Management Services G.12 Special Needs Services
More informationGetting Clinicians Involved: Testing Smartphone Applications to Promote Behavior Change in Health Care
Getting Clinicians Involved: Testing Smartphone Applications to Promote Behavior Change in Health Care Xiaomu Zhou 4 Huntington Street xmyzhou@rutgers.edu Lora Appel 4 Huntington Street lappel@eden.rutgers.edu
More informationHealth Insurance Benefits for Treatment of Tobacco Dependence. Summary
S U M M A R Y R E P O R T O F T H E P A C I F I C C E N T E R O N H E A L T H A N D T O B A C C O Health Insurance Benefits for Treatment of Tobacco Dependence Summary $ Why do tobacco users need health
More informationOhio Health Homes Learning Community Meeting. Overview of Health Homes Measures
Ohio Health Homes Learning Community Meeting Overview of Health Homes Measures Tuesday, March 5, 2013 Presenter: Amber Saldivar, MHSM Associate Director, Informatics Analysis Health Services Advisory Group,
More informationSmoking Cessation Program
Smoking Cessation Program UHN Information for people who are ready to quit smoking Read this information to learn: why you should quit smoking how the Smoking Cessation Program works treatments to help
More informationCHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT
CHAPTER 17: HEALTH PROMOTION AND DISEASE MANAGEMENT HEALTH SERVICES AND PROGRAMS The Plan s Health Promotion and Disease Management Department seeks to improve the health and overall well-being of our
More informationMedication Adherence: Rx for Success
Medication Adherence: Rx for Success Medication Adherence: Rx for Success Introduction Universal concern about rising health care costs combined with historic health care legislation has created an unprecedented
More informationAsthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association.
Asthma Intervention 1. Primary disease education Member will have an increased understanding of asthma and the classification by severity, the risks and the complications. Define asthma Explain how lungs
More informationCollaborative Onsite Medical Care in the Workplace
Collaborative Onsite Medical Care in the Workplace Sue Dierksen, MPH,RN, COHN-S/CM, CSP Director of Business Health- Aspirus Clinics Holly Bauer, RN BSN Health Services Supervisor, Sentry Insurance Objectives
More informationPfizer Medical Education Group Request for Proposals (RFP) Rheumatoid Arthritis Adherence to Medications for RA
Pfizer Medical Education Group Request for Proposals (RFP) Rheumatoid Arthritis Adherence to Medications for RA I. Background The Pfizer Medical Education Group (MEG) is the unit within Pfizer that provides
More informationThe Honorable Alphonso Maldon, Jr. Chairman Military Compensation and Retirement Modernization Commission P. O. Box 13170 Arlington, Virginia 22209
The Honorable Alphonso Maldon, Jr. Chairman Military Compensation and Retirement Modernization Commission P. O. Box 13170 Arlington, Virginia 22209 Dear Chairman Maldon: The National Association of Chain
More informationCOST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL
Malaysian Journal of Pharmaceutical Sciences, Vol. 5, No. 1, 19 23 (2007) COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL TRI MURTI ANDAYANI* AND IKE IMANINGSIH
More informationSelection of Medicaid Beneficiaries for Chronic Care Management Programs: Overview and Uses of Predictive Modeling
APRIL 2009 Issue Brief Selection of Medicaid Beneficiaries for Chronic Care Management Programs: Overview and Uses of Predictive Modeling Abstract Effective use of care management techniques may help Medicaid
More informationInformational Series. Community TM. Glossary of Health Insurance & Medical Terminology. (855) 624-6463 HealthOptions.
Informational Series Glossary of Health Insurance & Medical Terminology How to use this glossary This glossary has many commonly used terms, but isn t a full list. These glossary terms and definitions
More informationLicensed Healthcare Providers Guidelines for Telemedicine Using the MyDocNow Platform
Contents 1. Scope of These Guidelines... 2 2. What is Telemedicine?... 2 3. Introduction... 3 4. What Are the Benefits of Telemedicine?... 3 5. Frequently Asked Questions Physician Care and Treatment...
More informationTREATMENT MODALITIES. May, 2013
TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.
More informationHigh Desert Medical Group Connections for Life Program Description
High Desert Medical Group Connections for Life Program Description POLICY: High Desert Medical Group ("HDMG") promotes patient health and wellbeing by actively coordinating services for members with multiple
More informationA reliable and convenient way to optimize your prescription drug benefit
Introducing... Pharmacy Benefit Management and the Express Scripts Canada Pharmacy SM A reliable and convenient way to optimize your prescription drug benefit Did you know... that healthcare costs in Canada
More informationOutpatient Prescription Drug Benefit
Outpatient Prescription Drug Benefit GENERAL INFORMATION This supplemental Evidence of Coverage and Disclosure Form is provided in addition to your Member Handbook and Health Plan Benefits and Coverage
More informationThe Florida State University College of Medicine BCC 7175. Family Medicine 2012-2013. BCC 7175 2012-2013 Page 1 of 13
The Florida State University College of Medicine BCC 7175 Family Medicine 2012-2013 BCC 7175 2012-2013 Page 1 of 13 Table of Contents Instructors... 3 Education Director... 3 Clerkship Directors... 3 Course
More informationRobert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods
More informationCorporate Health Care Disjointed, Dysfunctional, Disastrous
Corporate Health Care Disjointed, Dysfunctional, Disastrous When you have done all you can do what s the next step? THE ISSUES: Three better words could hardly be found to describe the current status of
More informationCOOPERATIVE RESEARCH CENTRES PROGRAMME REVIEW
COOPERATIVE RESEARCH CENTRES PROGRAMME REVIEW Submission by November 2014 Page 1 ABOUT RESEARCH AUSTRALIA is an alliance of 160 members and supporters advocating for health and medical research in Australia.
More informationHow To Manage Chronic Illness
THE NEW FACE OF CHRONIC CARE MANAGEMENT By Joseph Berardo Jr., President and Chief Executive Officer, MagnaCare Introduction Over 75 percent of total health care spending in the U.S. will focus on chronic
More informationDoc Dial-in Discussion Series
Doc 2 Doc Dial-in Discussion Series Session 3: Universal Screening for Unhealthy Alcohol and Other Drug (AOD) Use Learning Objectives: (1) Understand the concept of universal screening (2) Learn how to
More informationProvider Manual. Section 18.0 - Case Management and Disease Management
Section 18.0 - Case Management and Disease Management 18.1.1 Introduction 18.2.1 Scope 18.3.1 Objectives 18.4.1 Procedures Case Management 18.4.1-A. Referrals 18.4.1-B. Case Management Mercy Maricopa Acute
More informationHealth-Related Lost Productivity: Causes And Solutions
Workplace Possibilities SM Health-Related Lost Productivity: Causes And Solutions Workplace Possibilities, by The Standard June 2012 Standard Insurance Company It is no secret that health care is on everyone
More informationConsultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
More informationSubmission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care
Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Services January 2015 1 IPU Submission to the Department
More informationThe Value of OTC Medicine to the United States. January 2012
The Value of OTC Medicine to the United States January 2012 Table of Contents 3 Executive Summary 5 Study Methodology 7 Study Findings 10 Sources 2 Executive Summary For millions of Americans, over-the-counter
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationPatient Education. Full Project. Description. Application in Office or at Home
Patient Education Full Project Description The World Health Organization defines patient education as any combination of learning experiences designed to help individuals improve their health, by increasing
More informationEvidence-Based Practice for Public Health Identified Knowledge Domains of Public Health
1 Biostatistics Statistical Methods & Theory Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health General Public Health Epidemiology Risk Assessment Population-Based
More informationTreatment of Chronic Pain: Our Approach
Treatment of Chronic Pain: Our Approach Today s webinar was coordinated by the National Association of Community Health Centers, a partner with the SAMHSA-HRSA Center for Integrated Health Solutions SAMHSA
More informationUnforeseen Benefits: Addiction Treatment Reduces Health Care Costs CLOSING THE ADDICTION TREATMENT GAP
Unforeseen Benefits: Addiction Treatment Reduces Health Care Costs CLOSING THE ADDICTION TREATMENT GAP Executive Summary Improving America s health care system, creating a healthier country, and containing
More informationHealth and Health Care for an Aging Population
Health and Health Care for an Aging Population May 2013 Policy Summary of The Canadian Medical Association December 2013 December 2013 Page 1 1) Introduction and Context: In 2010, 14% of Canada s population
More informationHealthCare Partners of Nevada. Heart Failure
HealthCare Partners of Nevada Heart Failure Disease Management Program 2010 HF DISEASE MANAGEMENT PROGRAM The HealthCare Partners of Nevada (HCPNV) offers a Disease Management program for members with
More informationIndiana s Health Care Sector and Insurance Market: Summary Report
MPR Reference No.: 6070 Indiana s Health Care Sector and Insurance Market: Summary Report Revised Final Report September 7, 2004 Deborah Chollet Fabrice Smieliauskas Rebecca Nyman Andrea Staiti Submitted
More information